Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010
Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts Source: Eur Respir J 2008; 31: 21-28 Year: 2008
Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007
Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway Source: Eur Respir J 2011; 37: 1237-1247 Year: 2011
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011
Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003
Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006
Forced oscillometry for early detection of bronchiolitis obliterans (BO) following hematogenous stem cell transplant (HSCT) Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012